Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 11:33 PM
Ignite Modification Date:
2025-12-24 @ 11:33 PM
NCT ID:
NCT02490956
Eligibility Criteria:
Inclusion Criteria:
* Case group
1. Patient with primary immunodeficiency diseases who follows up at Division of pediatric allergy and immunology unit, King Chulalongkorn Memorial Hospital
2. Subject or father/mother/legally acceptable representative properly informed about the study and having signed the informed consent form.
3. Subject is able to comply with the follow-up schedule of the protocol
* Control group
1. Subject is healthy (from history and physical examination)
2. Subject do not has underlying diseases.
3. Subject do not has primary and secondary immunodeficiency diseases
4. Subject is not receiving immunosuppressive therapy or cytotoxic drugs
5. Subject or father/mother/legally acceptable representative properly informed about the study and having signed the informed consent form.
6. Subject is able to comply with the follow-up schedule of the protocol
7. Age more than 12 month old to 60 years old
Exclusion Criteria:
1. Reported history of previous rabies immunization or Rabies neutralizing antibody (Rabies Nab) \> 0.5 IU/ml
2. Subject is unable to comply with the follow-up schedule of the protocol
3. Pregnancy
4. Body temperature more than 38 degree celcius at screening visit
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
12 Months
Maximum Age:
60 Years
Study:
NCT02490956
Study Brief:
Protocol Section:
NCT02490956